75 reports

  • 12.9 SOUTH AFRICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025

Whereas, the percentage for the women lies in between ##% to ##%.

  • Cardiovascular Disease
  • World
  • Forecast
  • Market Size
  • Medtronic, Inc.

Tuberculosis remains the global threat to people living with HIV.

  • Cardiovascular Disease
  • World
  • Forecast
  • Market Size
  • Bio-Rad Laboratories, Inc.

FIGURE ##. ##.

  • Cardiovascular Disease
  • World
  • Forecast
  • Market Size
  • Medtronic, Inc.

It enables doctors and researchers in the detection of various infectious diseases such as Chlamydia trachomatis/ Neisseria gonorrhoeae infection and pulmonary tuberculosis.

  • Cardiovascular Disease
  • Point Of Care Testing
  • World
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.

Top ## players hold majority of stake in the market ##.

  • Cardiovascular Disease
  • World
  • Market Size
  • Baxter International Inc.
  • Gilead Sciences, Inc.

STEM CELL REPORTS; ##(##): ##-## ##(##): ##-## ##(##): ##-## IN CARDIOLOGY (JCARE-CARD).

  • Cardiovascular Disease
  • Market Size
  • Bristol-Myers Squibb Company
  • Les Laboratoires Servier SAS
  • Novartis AG
  • Mexico Vascular Access Device Market Size, By Value, 2014-2024 (USD Billion)

language_id=## Vascular Access.

  • Cardiovascular Disease
  • World
  • AngioDynamics, Inc.
  • B.Braun Melsungen AG
  • Becton, Dickinson and Company, Ltd
  • CERENIS THERAPEUTICS' DYSLIPIDEMIA PORTFOLIO ASSESSMENT, 2015
  • PRESENTS CERENIS THERAPEUTICS' DYSLIPIDEMIA PORTFOLIO.

PLOS ONE; ##(##): ##-##.

  • Cardiovascular Disease
  • AstraZeneca PLC
  • Cerenis
  • Merck & Co., Inc.
  • The Medicines Company
  • NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE, PHARMACEUTICALS & HEALTHCARE, DEAL DETAILS

Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Pharmaceuticals and Healthcare No. of Deals ## ## ## ## ## ## Deal Value (US$ million) NA NA NA NA NA NA Note: Deals include all announced pharmaceuticals & healthcare

  • Cardiovascular Disease
  • Mental Health
  • Neurological Disorder
  • Stroke
  • United States
  • 3.3.1 DRIVERS AND OPPORTUNITIES

AND ABIOMED (U. S. ) ##.

  • Cardiovascular Disease
  • World
  • Market Size
  • Boston Scientific Corporation
  • Medtronic, Inc.

Arteriosclerosis, Thrombosis, and Vascular Biology, ##(##): ##-##. ##(##): ##-##.

  • Cardiovascular Disease
  • Amgen Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.

TERM=SPIRE+##& RANK=##.

  • Cardiovascular Disease
  • World
  • Market Size
  • Amgen Inc.
  • AstraZeneca PLC

Jude Medical List of Exhibits ##: Executive Summary Table ##-##: The Global Market for Advanced Patient Monitoring Systems, 2012-2021 ##: Advanced Patient Monitoring Products and Technologies Table ##-##: Clinical Trial Activity by Industry Participant Figure ##-

  • Cardiovascular Disease
  • Patient Monitoring
  • Telemedicine
  • World
  • Forecast

TB = tuberculosis.

  • Cardiovascular Disease
  • World
  • Cepheid
  • Hologic, Inc.
  • Roche Group

This is one of the largest acquisitions in the medical device industry.

  • Cardiovascular Disease
  • World
  • Boston Scientific Corporation
  • Cordis Corporation
  • Johnson & Johnson

Additional assays could be developed for the platform, including tuberculosis.

  • Cardiovascular Disease
  • Cholesterol
  • Abaxis, Inc.
  • Alere Inc.
  • PTS DIAGNOSTICS

IT AFFECTS ## IN ##, ## TO ## IN ##, ## BIRTHS.

  • Cardiovascular Disease
  • Clinical Trial
  • Hospital
  • Mental Health
  • AutoGenomics, Inc.

The period saw the launch of the Genedrive®tuberculosis (TB) and associated antibiotic resistance test in India.

  • Cardiovascular Disease
  • Clinical Trial
  • Infectious Disease
  • Point Of Care Testing
  • Grifols, S.A.

These limitations are expected to restrain market growth. ##. ##. ##. ##. ## In 2018, North America accounted for the largest share of ##. ##% of the eye drops market.

  • Cardiovascular Disease
  • Topical Delivery
  • North America
  • United States
  • Pfizer Inc.

Similarly, the universities portfolio in Preclinical and Discovery stages comprises ## and ## molecules, respectively.

  • Cardiovascular Disease
  • Therapy
  • United States
  • Product Initiative
  • Synovo GmbH

The broad-spectrum anti-microbial property of nitric oxide widens the enrollment eligibility of subjects in this Phase ## trial with the only exclusion being for Non-Tuberculosis Mycobacterium (NTM), which will be studied in separately planned trials.

  • Cardiovascular Disease
  • Therapy
  • United States
  • World
  • NicOx S.A.

The COPD is classified into diseases such as asthma, lung cancer, tuberculosis, pneumonia, obstructive sleep apnea syndrome and cystic fibrosis.

  • Cardiovascular Disease
  • World
  • Forecast
  • Market Size
  • Medtronic, Inc.

Similarly, the universities portfolio in Preclinical and Discovery stages comprises ## and ## molecules, respectively.

  • Cardiovascular Disease
  • Dementia
  • Therapy
  • United States
  • Product Initiative

The study included two active dosing regimens: (##) ## mg once-daily for days ## to ##, and (##) ## mg twice daily for days ## to ## followed by ## mg once-daily for days ## to ##.

  • Blood Disease
  • Cardiovascular Disease
  • Hospital
  • Therapy
  • NicOx S.A.

It undertakes extensive research and development of pharmaceuticals for treatment of migraine, gastrointestinal, psoriasis, central nervous system, cardiovascular, tuberculosis, diabetes and inflammation.

  • Cardiovascular Disease
  • Endocrine Disease
  • United States
  • World
  • Boehringer Ingelheim GmbH

DPN is one of the common complications of diabetes that manifests symptoms of neuropathic pain.

  • Cardiovascular Disease
  • Type 2 Diabetes
  • United States
  • Product Initiative
  • ViroMed Co., Ltd.
  • PIPELINE BY BIOCAD, H2 2018
  • PIPELINE BY BIOLEADERS CORP, H2 2018

The company' s project pipeline includes oral products with therapeutic application in the area of diabetes type II, leishmaniasis and tuberculosis.

  • Cardiovascular Disease
  • Monoclonal Antibody
  • United States
  • Product Initiative
  • Regeneron Pharmaceuticals, Inc.

One unit refers to one S-ICD.

  • Cardiovascular Disease
  • Patient Monitoring
  • United States
  • Demand
  • Medtronic, Inc.

This resulted in an EPS (before non-cash items) of ##. ## cents which, whilst lower than the equivalent quarter last year, was higher than the ## cent per ADR reported in quarter one of this year. "

  • Antimalarials
  • Cardiovascular Disease
  • Clinical Trial
  • United States
  • bioMerieux S.A.

One unit refers to one vascular graft.

  • Cardiovascular Disease
  • Clinical Trial
  • General Medicine And Specialty Medicine
  • United States
  • Humacyte, Inc.